The effect of diluted ropivacaine in uterine distending fluid on pain after hysteroscopy surgeries
- Conditions
- Pain after hysteroscopic surgery in gynecological diseases.
- Registration Number
- IRCT20160527028109N4
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Women candidates for hysteroscopy treatment based on the opinion of a specialist
Conscious consent to participate in the study
Existence of pelvic inflammatory disease
Having known cervical malignancy, severe uterine bleeding, cervical conization
Need for intraoperative surgery due to complications (such as laparotomy due to uterine perforation)
Having psychological or neurological disorders that affect pain perception.
Allergy to rupivacaine
Reluctance to continue cooperation while studying
Patients with chronic diseases with pain such as low back pain, etc. who use continuous painkillers.
Patients have previously had a tubectomy or have a bilateral obstruction of the tube.
Patients with preoperative pelvic pain, dyspareunia, dysmenorrhea, with a vas score of 3 or higher.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intensity and frequency of pain. Timepoint: 6, 12, 24 and 48 hours after hysteroscopy. Method of measurement: Questionnaire and patient file.
- Secondary Outcome Measures
Name Time Method